232 related articles for article (PubMed ID: 23226054)
1. Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family.
Lucire Y; Crotty C
Pharmgenomics Pers Med; 2011; 4():65-81. PubMed ID: 23226054
[TBL] [Abstract][Full Text] [Related]
2. The relevance of cytochrome P450 polymorphism in forensic medicine and akathisia-related violence and suicide.
Eikelenboom-Schieveld SJ; Lucire Y; Fogleman JC
J Forensic Leg Med; 2016 Jul; 41():65-71. PubMed ID: 27138119
[TBL] [Abstract][Full Text] [Related]
3. Psychoactive Medication, Violence, and Variant Alleles for Cytochrome P450 Genes.
Eikelenboom-Schieveld SJM; Fogleman JC
J Pers Med; 2021 May; 11(5):. PubMed ID: 34069803
[TBL] [Abstract][Full Text] [Related]
4. Treatment Emergent Violence To Self And Others; A Literature Review of Neuropsychiatric Adverse Reactions For Antidepressant And Neuroleptic Psychiatric Drugs And General Medications.
Clarke C; Evans J; Brogan K
Adv Mind Body Med; 2019 Winter; 33(1):4-21. PubMed ID: 31370036
[TBL] [Abstract][Full Text] [Related]
5. Applications of CYP450 testing in the clinical setting.
Samer CF; Lorenzini KI; Rollason V; Daali Y; Desmeules JA
Mol Diagn Ther; 2013 Jun; 17(3):165-84. PubMed ID: 23588782
[TBL] [Abstract][Full Text] [Related]
6. Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital.
Ruaño G; Villagra D; Rahim US; Windemuth A; Kocherla M; Bower B; Szarek BL; Goethe JW
Per Med; 2008 Nov; 5(6):579-587. PubMed ID: 29788619
[TBL] [Abstract][Full Text] [Related]
7. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
8. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
de Leon J; Susce MT; Murray-Carmichael E
Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
[TBL] [Abstract][Full Text] [Related]
9. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
[TBL] [Abstract][Full Text] [Related]
10. Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.
Yenilmez ED; Tamam L; Karaytug O; Tuli A
Comb Chem High Throughput Screen; 2018; 21(5):374-380. PubMed ID: 29921201
[TBL] [Abstract][Full Text] [Related]
11. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.
de Leon J; Armstrong SC; Cozza KL
Psychosomatics; 2006; 47(1):75-85. PubMed ID: 16384813
[TBL] [Abstract][Full Text] [Related]
12. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
Skadrić I; Stojković O
Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. To Genotype or Phenotype for Personalized Medicine? CYP450 Drug Metabolizing Enzyme Genotype-Phenotype Concordance and Discordance in the Ecuadorian Population.
De Andrés F; Terán S; Hernández F; Terán E; LLerena A
OMICS; 2016 Dec; 20(12):699-710. PubMed ID: 27849442
[TBL] [Abstract][Full Text] [Related]
15. Complications of Psychotropic and Pain Medications in an Ultrarapid Metabolizer Patient at the Upper 1% of Cytochrome P450 (CYP450) Function Quantified by Combinatorial CYP450 Genotyping.
Ruaño G; Larsen K; Kocherla M; Graydon JS; Kost J
J Pain Palliat Care Pharmacother; 2017 Jun; 31(2):126-138. PubMed ID: 28506184
[TBL] [Abstract][Full Text] [Related]
16. CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.
Arici M; Özhan G
Saudi Pharm J; 2017 Mar; 25(3):376-380. PubMed ID: 28344492
[TBL] [Abstract][Full Text] [Related]
17. Interaction between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro.
Cheng HX; Lu YY; Wang X; Ren H; Li Q; Wang SM; Ding Y; Lou YQ; Zhang GL
Eur J Pharm Sci; 2018 Oct; 123():241-248. PubMed ID: 30010032
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
19. Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.
Roco A; Quiñones L; Agúndez JA; García-Martín E; Squicciarini V; Miranda C; Garay J; Farfán N; Saavedra I; Cáceres D; Ibarra C; Varela N
Front Genet; 2012; 3():229. PubMed ID: 23130019
[TBL] [Abstract][Full Text] [Related]
20. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
Jin SE; Seo CS; Shin HK; Ha H
Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
